CURI vs NXST

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 24, 2026

CURI

41.0
AI Score
VS
NXST Wins

NXST

48.2
AI Score

Investment Advisor Scores

CURI

41score
Recommendation
HOLD

NXST

48score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CURI NXST Winner
Forward P/E 13.7741 5.3996 NXST
PEG Ratio 0 0.1714 Tie
Revenue Growth 22.3% 62.2% NXST
Earnings Growth 1400.0% 18.0% CURI
Tradestie Score 41.0/100 48.2/100 NXST
Profit Margin 0.0% 3.2% NXST
Beta 1.00 1.00 Tie
AI Recommendation HOLD BUY NXST

Relative Price Performance (Last 90 Days)

CURI 1M: +20.9% · 3M: +11.4% NXST 1M: +1.6% · 3M: -1.3%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.7 · Price: $2.84

NXST

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 49.7 · Price: $186.24

Fundamentals Snapshot

Metric CURI NXST
Market Cap
Forward P/E 9.2 8.0
Trailing P/E 35.3
Revenue (TTM)
Revenue Growth 0.2% 0.6%
Gross Margin 0.6% 0.6%
Operating Margin 0.4% 0.2%
EPS -0.01 5.28
Dividend Yield 0.11% 0.04%

Frequently Asked Questions

Based on our detailed analysis, NXST is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.